Scolaris Content Display Scolaris Content Display

Taxane‐platinum combination chemotherapy versus single agent platinum for the first‐line treatment of epithelial ovarian cancer

Esta versión no es la más reciente

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:

To evaluate the benefit and harms of adding a taxane to platinum therapy compared to platinum chemotherapy alone for the primary management of epithelial ovarian, fallopian tube or peritoneal epithelial adenocarcinoma.